Us Bancorp \De\ Genfit S.A. Transaction History

Us Bancorp \De\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 10, 2020	SELL	$3.67 - $5.59 $1,343 - $2,045	-366 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$5.2 - $22.0 $4,123 - $17,446	-793 Reduced 68.42%	366 $2,000
Q1 2020 May 13, 2020	SELL	$10.95 - $20.76 $1,653 - $3,134	-151 Reduced 11.53%	1,159 $17,000
Q4 2019 Feb 04, 2020	BUY	$13.55 - $20.14 $17,750 - $26,383	1,310 New	1,310 $26,000

209K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $205M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.